Most principles of protein folding emerged from refolding studies in vitro on small, soluble proteins, because large ones tend to misfold and aggregate. We developed a folding assay allowing the study of large proteins in detergent such that the extent of cellular assistance required for proper folding can be determined. We identified a critical step in the in vivo folding pathway of influenza virus hemagglutinin (HA). Only the formation of the first few disulfides in the top domain of HA required the intact endoplasmic reticulum. After that, HA proceeded to fold efficiently in a very dilute solution, despite its size and complexity. This study paves the way for detailed structural analyses during the folding of complex proteins.
A critical step in the folding of influenza virus HA determined with a novel folding assay M Claudia Maggioni 1,2 , I Marije Liscaljet 1,2 & Ineke Braakman 1 Most principles of protein folding emerged from refolding studies in vitro on small, soluble proteins, because large ones tend to misfold and aggregate. We developed a folding assay allowing the study of large proteins in detergent such that the extent of cellular assistance required for proper folding can be determined. We identified a critical step in the in vivo folding pathway of influenza virus hemagglutinin (HA). Only the formation of the first few disulfides in the top domain of HA required the intact endoplasmic reticulum. After that, HA proceeded to fold efficiently in a very dilute solution, despite its size and complexity. This study paves the way for detailed structural analyses during the folding of complex proteins.
Protein folding is the process by which linear polypeptide chains acquire their biologically active three-dimensional conformation. Although all information needed to reach the native conformation is encoded by the amino acid sequence 1 , protein folding inside the cell generally is assisted by molecular chaperones and folding enzymes [2] [3] [4] . They mainly protect nascent chains and newly synthesized proteins from misfolding and aggregation. Chaperones and folding enzymes reside in almost every compartment of eukaryotic cells.
The endoplasmic reticulum (ER) is highly specialized for the folding of membrane and secretory proteins. One of the bestcharacterized model proteins used to study protein folding in the ER is the influenza virus HA. This protein is not only crucial for influenza virus infection but also an important target for the immune system. HA is a multidomain glycoprotein of 84 kDa with six disulfide bonds and seven N-linked glycans. It folds in the ER, trimerizes and is transported to the plasma membrane, where it is incorporated into new virions. The folding of HA has been studied extensively both in complete cells [5] [6] [7] [8] [9] [10] [11] and in microsomes 12, 13 , using radioactive labeling of newly synthesized HA or truncated ribosome-bound nascent chains 14 . Although these studies yielded fairly detailed information on the HA folding process, further molecular insight would require biophysical studies on purified protein, which would disregard the role of the cell.
To start bridging the gap between folding studies in vitro and in intact cells, we developed an assay that allows the study of post-translational HA folding in a cell-free system without membranes. We replaced the chase period in the well-established pulse-chase folding assay 6 with a folding analysis in solution: the protein is translated and translocated in intact cells, after which post-translational folding is studied in a detergent cell lysate. Using this 'in vitro chase' assay, we found that HA can fold in a detergent cell lysate without ER assistance, provided that the first folding step occurs in an intact ER.
RESULTS

HA can fold in a detergent cell lysate
When studied with the pulse-chase assay in intact cells, newly synthesized HA ran as a single band in a reducing SDS-PAGE gel (Fig. 1a, R) and as three bands in a nonreducing gel: the native, fully oxidized HA (NT) and two folding intermediates, IT1 and IT2 (Fig. 1a, NR) 6 . The two folding intermediates have lower electrophoretic mobility than NT because they still lack some of the six disulfide bonds, which render them less compact upon denaturation than NT. Even though the first two disulfide bonds always form during translation 14 , most of HA's folding occurs post-translationally 6, 10 .
For the in vitro-chase assay, influenza-infected cells were pulse-labeled for 2 min as in the pulse-chase assay, to translate HA in vivo. Cells were lysed immediately in a detergent-containing buffer and kept on ice. The nuclei were removed by centrifugation and the supernatant was transferred to an eppendorf tube. The diluted cell lysate contained detergent micelles instead of intact membranes, including radiolabeled folding intermediates of glycosylated full-length HA from which the signal peptide had been cleaved. We then started the oxidative in vitro folding process of HA by increasing the temperature and adding oxidized glutathione (GSSG). After various times of incubation, the in vitro chase was stopped as a conventional chase by cooling the sample on ice and alkylating the remaining free cysteines with N-ethylmaleimide (NEM) to block further disulfide bond formation.
HA folding in this very dilute system (Fig. 1b) was very similar to folding in intact cells (Fig. 1a) : HA folded to NT and aggregates were undetectable; even the rate of folding was similar. The process was very efficient: we saw an increase from 27% NT to 70% NT during the in vivo chase (Fig. 1a) and an increase from 30% NT to 58% NT during the in vitro chase (Fig. 1b) . The percent of NT was quantified as the ratio of the amount of NT to the total amount of HA in every lane (NT/total HA). We discounted aggregates because the fraction was low and did not change during the assay in CHO cells. Despite the overall similarity between the two folding assays, small differences could be seen: IT1 was not a sharp band at the beginning of the in vitro assay (Fig. 1b, lane 1) , because the free cysteines in the sample were not immediately blocked by NEM in order to allow oxidative folding of the protein during the in vitro chase period. We have previously shown that IT1 is not stable in a cell lysate 6 . We experimentally determined that addition of 1 mM DTT to the lysis buffer was sufficient to keep IT1 as a sharp band without affecting the folding process of HA (Fig. 1c, lanes 1-6) . Under these conditions, folding intermediates now were stable for at least 30 min if kept on ice in the absence of glutathione (Fig. 1c, lane 7) . The downward shift of the NT band from lane 1 to lane 2 in Figure 1a , representing glucose (and perhaps already some mannose) trimming, was not present in vitro (Fig. 1c, lanes 1 and 2) . The slight decrease in sharpness of HA folded in vivo at later time points (Fig. 1a, lanes 4-6) , caused by complex glycosylation in the Golgi, was absent in vitro as well, as expected. Another difference with folding in intact cells was the appearance of a band between IT1 and IT2 in vitro (Fig. 1b, lanes 2-6) . Its persistence suggests it to be an off-pathway form not leading to NT. This band is probably not the result of carbohydrate trimming because it appears only in nonreducing gels of the in vitro chase assay and in some cysteine mutants (A. Azuaga-Fortes, Utrecht University, and I.B., unpublished observations).
The cell lysate contained all factors present in the intact cell but in highly diluted form. To characterize our in vitro chase lysate and to demonstrate whether dilution and the presence of detergent interfered with the binding of chaperones and folding factors, we used antibodies against molecular chaperones known to bind HA in intact cells [15] [16] [17] . At the start of the in vitro chase assay, HA was found in a complex with calnexin (CNX) and calreticulin (CRT), but we did not detect association with ERp57 (data not shown), BiP or PDI (Fig. 1d) .
HA folded in vitro acquires correct epitopes
To confirm conformational and antigenic resemblance between HA folded in the intact cell versus HA folded in the cell lysate, we used a series of conformation-specific antibodies (Fig. 2) . As shown in the schematic structure of HA (Fig. 2a) , F1 and F2 are monoclonal antibodies against epitopes in the stem domain that recognize early and late folding intermediates, respectively 6, 7 . In vivo, F1 recognizes only the relatively unfolded forms of HA: it precipitates reduced HA, folding intermediate IT1 and folding intermediate IT2, but not the native NT form 6, 7 . In contrast, F2 precipitates IT2 and early NT, but not IT1 or mature trimeric HA 6, 10, 18 . The monoclonal antibodies HC3, HC19 and HC100 recognize epitopes A, B and E in the top domain (Fig. 2a) , which are formed in some HA chains already during synthesis and in others immediately after synthesis 18 , indicating heterogeneity in the folding process. These epitopes persist throughout HA's lifetime 18 . We concluded from the immunoprecipitations of in vitro-chased samples with the five antibodies (Fig. 2b) that each antibody reacted with the different forms of HA as expected 6, 10, 18 : the A, B, and E epitopes were present both early (0 min) and late (30 min), whereas the F1 antibody recognized little HA after a 30-min in vitro chase. F2 did not detect IT1 and immunoprecipitated IT2 and NT, but instead of a decrease in recognition with time, it interacted strongly with NT at 30 min. In vivo, F2 loses its epitope around the time of HA trimerization, and HA is not likely to trimerize in this diluted system in the absence of membranes 18, 19 . Indeed, HA trimers were not detectable after folding in the lysate: HA did not precipitate with the trimer-specific antibody N2, and did not reach trypsin resistance as it does in vivo 20 (data not shown). Taken together, the results show that in a cell lysate in the absence of an intact ER, HA monomers folded into their proper, native conformation with high efficiency.
Reduced HA cannot fold in a cell lysate
We demonstrated that HA folds properly in a detergent cell lysate, even though this protein is large and complex. On the other hand, the starting point of the folding assay was not an unfolded protein, but rather an HA molecule partially folded during translation. To study whether the detergent cell lysate would also support the earlier steps of folding, we prevented oxidative folding in vivo by pulse-labeling HA in the presence of DTT (Fig. 3) . In intact cells, disulfide bond formation can be postponed successfully until synthesis is completed: HA starts to form its disulfide bonds as soon as DTT is removed (Fig. 3a,  lane 2) , with little adverse effect on the outcome of folding 7,21 as confirmed by analysis with conformation-specific antibodies (Fig. 3c) .
During the in vitro chase assay, the reduced and largely unfolded HA oxidized in the lysate upon addition of GSSG, but distinct folding intermediates did not appear (Fig. 3b) . The fraction of HA that aggregated increased, and NT did not form. In some experiments (Fig. 3d, lane  2, and Fig. 5a, lane 6) , oxidation went as far as an NT-like form, but analysis with conformation-specific antibodies confirmed that none of the top domain epitopes were ever formed (Figs. 3d (only the E epitope is shown) and 5b). In addition, F2 did not recognize any of the oxidized forms, whereas F1 still recognized some reduced HA after the in vitro chase. We concluded that HA could not fold from a completely reduced state in the absence of an intact ER; it needed to acquire some disulfide bonds in vivo first.
The presence of DTT during HA synthesis prevented the formation of disulfide bonds as well as the acquisition of some conformation 7 that could be crucial for productive folding in the cell lysate. We tested whether post-translational reduction of partially oxidized HA would allow folding in the cell lysate, which would suggest maintenance of critical conformation acquired during synthesis, despite reduction of the already formed disulfide bonds. In other words, we analyzed whether the history of the reduced HA molecule or its state at the start of the in vitro folding phase determined its competence for folding. The results showed that, irrespective of whether HA had formed disulfide bonds during synthesis, the reduced protein could not fold in the lysate (data not shown). Reduced HA folds in vivo without CNX or CRT Whereas partially folded HA did fold in the absence of an intact ER, completely reduced HA did not (Figs. 3b and 5a) . Because CNX binding to HA is inhibited by the presence of DTT 16 we needed to check whether lack of CNX rebinding in vitro caused improper oxidation of HA in vitro. To exclude a role for CNX, we used CHO-derived Lec23 cells, which lack glucosidase I activity and therefore do not support CNX or CRT association with substrate proteins in the ER 22 . We reasoned that proper folding from reduced HA should not be possible in the Lec23 cells if CNX or CRT were essential for this step. We therefore compared folding of HA in intact Lec23 cells (Fig. 4) without DTT (as in Fig. 1a ) and with DTT (as in Fig. 3a) in the pulse medium. Because HA needs CNX for folding 11 , a relatively large fraction of HA aggregated in the control experiment without DTT (Fig. 4a) . When HA was synthesized in the presence of DTT (Fig. 4b) , the portion that aggregated was similar to that in Figure 4a , but the rest of HA folded to NT in the cell (Fig. 4b , lanes 4 and 5) and trimerized (data not shown). We concluded that, even in the absence of CNX binding, HA can fold from the reduced form in vivo. Clearly, in the in vitro assay, HA itself could not nucleate proper folding from the reduced state.
The critical step during HA folding
To determine the minimal conformation that needed to form in the intact ER for productive folding in solution, we pulse-labeled HA in the presence of DTT, followed by short in vivo 'rescue chases' without DTT (Fig. 5) . With increasing times of rescue chase, from 0 to 1 or 5 min (Fig. 5a,c,e , lane 1), HA acquired an increasing number of disulfide bonds and native epitopes in the intact ER, before lysis of the cells and the start of the in vitro folding phase. The longer the in vivo rescue time, the more NT had formed after 30 min of in vitro chase (compare lane 6 in Fig. 5a,c,e) . Although HA was still mainly in the form of R/IT1 after only 1 min of rescue (Fig. 5c,  lane 1) , a large fraction of HA could fold to NT in the lysate (Fig. 5c,  lane 6) . We concluded that formation of IT2 was not a prerequisite to reach the NT form in vitro. Analysis of the 30-min in vitro chase samples with the conformation-specific antibodies (Fig. 5b,d,f) confirmed that, whereas neither the top domain epitopes nor F2 were present immediately after the pulse (Fig. 5b) , all the top domain epitopes as well as the F2 epitope had formed already when a 1-min rescue in intact cells was allowed before the in vitro chase (Fig. 5d) . In agreement with this, the F1 epitope disappeared (compare lane 5 in Fig. 5d,f and Fig. 5b) . We concluded that formation of the first two disulfides (IT1), or perhaps even only the first one, was sufficient to allow productive HA folding during the in vitro chase.
To confirm that rebinding of CNX during the in vivo chase was not the reason for the rescue of HA folding in vitro, we repeated the experiment shown in Figure 5 in Lec23 cells (Fig. 6) . Aside from the aggregates and the slower folding from reduced HA in Lec23 cells, the results were similar to those for the CHO cells, showing that the absence or presence of CNX binding is not the source of the difference in folding competence of reduced HA versus IT1. Combining our results from the Lec23 cells, we conclude that CNX and CRT are not needed for passing the bottleneck in vivo, and do not play an essential role in the subsequent folding of HA to NT in vitro.
A previous study showed that disulfide 1 (64-76) in the top domain of HA can already form on the nascent chain 14 . Because IT2 corresponds to the closure of disulfide 4 (52-277) and NT corresponds to closure of disulfide 6 (14-466) 10 (I.B. et al., unpublished data), our results suggest that only the first few small disulfide bonds need to form in vivo to allow further folding of HA in the detergent lysate. Combining all our results, Figure 5 The bottleneck of HA folding: formation of the first few disulfides. Samples were prepared and analyzed as in Figure 3b. (a-f) Nonreducing gels (a, c and e) and both nonreducing and reducing gels (b, d and f) are shown. The starting point of the in vitro chase was either completely reduced HA from a pulse in DTT (a, as in Fig. 3b) , or HA pulse-labeled in the presence of DTT, but rescued in a chase in intact cells without DTT for 1 min (c) or 5 min (e). Analysis of a 30 min in vitro chase sample, rescued for 0 (b), 1 (d) or 5 (f) min in vivo, with conformation-specific antibodies. Different exposure times were used for the immunoprecipitation with P versus the conformational antibodies. we conclude that, whereas the major part of HA folding works in a highly diluted cell lysate, an intact ER is required for the formation of the first small disulfide bond(s) in HA's top domain.
DISCUSSION
We established a new in vitro assay for the folding of large, complex proteins based on our 'pulse-chase' folding assay in intact cells. Using this assay, we identified a bottleneck in the folding of influenza virus HA: the protein folded properly and productively in a highly diluted detergent cell lysate provided its first small disulfides were formed in the intact ER. The HA molecules folded in vitro correctly in every determinable aspect.
HA is structured like a hairpin 23 that folds from the tip of the bend, the top domain, toward the N and C terminus of the ectodomain at the bottom of the stem 10 . Our results indicate that the critical step during HA folding is the formation of IT1, which in vivo occurs cotranslationally and involves the closure of the first two small disulfide loops in the top domain of HA, 1 (64-76) and 2 (97-139) 10,14 (I.B. et al., unpublished data). We indeed found that mutation of the disulfide bond 1 (64-76) in the top domain completely blocked folding of HA beyond R/IT1. It is no surprise to us that the most critical of the seven glycans present in HA also resides in this area, at position 81 (ref. 16) .
Although formation of IT1 always occurs cotranslationally 10,14 , this step can be postponed until after synthesis in the intact cell 7, 10 . From these and other in vivo data we had concluded before that the termination of translation does not correlate with a specific folding step in HA, but that certain folding steps occur sometimes during and sometimes after synthesis. We have now identified an early step in HA folding that has three characteristics: it is the most critical, it is always cotranslational 6, 7, 10 , and it can occur post-translationally in vivo but not in vitro. This may not be a coincidence. Perhaps sequential folding of the HA nascent chain during translation and/or protection by the ribosome-translocon complex 24 does contribute to the passage of this critical step.
If it does not happen on the nascent chain, formation of IT1 clearly needs assistance from chaperones and folding enzymes, assistance that is lacking in our in vitro chase assay. CNX and CRT were still found associated with HA in vitro, but although these and other chaperones and folding enzymes are still present in the detergent lysate, they were diluted so much that they are unlikely to exhibit their physiological activity, especially when cochaperones are involved 25 . We were thus not surprised that we found no essential role for CNX and CRT during in vitro folding. Our assay distinguished the early, critical ER-dependent step from the later, ER-independent stages of HA folding: formation of the first disulfide(s) in the top domain region is required but also sufficient to allow further folding without extensive ER assistance in a detergent cell lysate. Considering the virtually complete conservation 26, 27 of the 12 cysteines in HA of all influenza strains, the identification of HA's Achilles' heel opens new avenues for the design of antiviral drugs.
An earlier attempt to study folding of a viral protein in vitro used the VSV-G protein purified from the mature virion: VSV-G folded with very low efficiency and ∼50% aggregation 28 . Other cell-free studies with complex proteins 12, 29 are based on microsomes; the possibility of modulating the folding environment is limited and protein synthesis and translocation seem less efficient than in living cells.
The assay we developed presents the advantages of both in vivo and in vitro studies: the protein of interest is synthesized in an intact cell, ensuring that post-translational modifications occur and that correct initial assistance is given; the option to modulate the 'in vivo' phase in nature and length combined with the high dilution of the in vitro chase allows the determination of how long cellular assistance is needed during the folding process and whether any ER-independent folding step exists. The lack of membranes in the second phase of the experiment allows easy manipulation of the folding milieu. It now has become possible to study complex, large, multidomain proteins in a highly diluted solution. With this assay, we constructed another segment of a bridge between in vitro and in vivo folding studies.
METHODS
Cell lines, viruses, and HA expression. Chinese hamster ovary cells (CHO) were cultured in αMEM (Gibco-BRL) and Lec23 cells 22 in αMEM with nucleosides (Gibco-BRL) supplemented with 8% (v/v) FCS (Gibco-BRL), 100 U ml -1 each of streptomycin and penicillin and 2 mM glutamax (Gibco-BRL).
The X31 strain of influenza virus, A/Aichi/1968/H3N2, was used for all infections. Cells were infected in RPMI medium, 0.2% (w/v) BSA, 10 mM HEPES, pH 6.8, and rocked at 37 °C in the absence of CO 2 . After 1 h, complete culture medium was added to the dishes, which were then incubated at 37 °C in the presence of CO 2 .
Recombinant vaccinia virus expressing T7 polymerase 30 was used for HA expression (Fig. 4) . Subconfluent Lec23 cells were infected and transfected as described 31 and incubated at 37 °C.
In vivo pulse-chase analysis of HA. Subconfluent CHO cells (unless indicated otherwise) were pulse-labeled 5 h after infection with influenza or recombinant vaccinia virus 6 . Metabolic labeling was done as described 6 . Briefly, cells were starved for 15-30 min in cysteine-and methionine-free medium and then pulsed for 2 min with Revidu PRO-MIX L-[ 35 S] in vitro cell labeling mix (Amersham Biosciences). When indicated, a 5-min preincubation and a 5-min pulse were carried out in the presence of 5 mM DTT, followed or not by a chase for different times with an excess of unlabeled cysteine and methionine. Chase samples were stopped by aspirating the medium and adding ice-cold HBSS (Gibco-BRL) containing 20 mM NEM (Sigma) to block the free sulfhydryl groups. Cells were lysed in cold MNT (20 mM MES, 100 mM NaCl, 30 mM Tris-HCl, pH 7.5) containing 0.5% (v/v) Triton X-100, 10 µg ml -1 each of chymostatin, leupeptin, antipain and pepstatin and 1 mM PMSF. Cell lysates were spun for 10 min at 15,000g to pellet the nuclei and supernatants were used for immunoprecipitation.
In vitro chase assay. CHO or Lec23 cells were pulse-labeled with or without 5 mM DTT in intact cells as described above. After the pulse (and sometimes a short chase), cells were washed twice with ice-cold HBSS (Gibco-BRL), immediatly lysed with ice-cold MNT (20 mM MES, 100 mM NaCl, 30 mM Tris-HCl, pH 7.5) containing 0.5% (v/v) Triton X-100, 10 µg ml -1 each of chymostatin, leupeptin, antipain and pepstatin and 1 mM PMSF. After scraping of cells, 20 mM NEM was immediately added to 1/6 of the lysate (this is the 0-min sample of the in vitro assay). All cell lysates were then centrifuged for 10 min at 15,000g and 4 °C to pellet nuclei. The supernatant of the lysate without NEM was transferred to a new tube for the in vitro chase assay. To start the in vitro folding phase, 5 mM GSSG (Roche) was added and the tube was immediately transferred to a 30 °C waterbath. After different times of incubation, part of the lysate was transferred to a new tube on ice containing NEM to a final concentration of 20 mM to block free cysteines. Samples were kept on ice until being subjected to immunoprecipitation.
Immunoprecipitation and SDS-PAGE.
Immunoprecipitations were carried out as described 6 with a polyclonal rabbit antiserum against the N terminus of HA, when indicated (NHA), or with a polyclonal rabbit antiserum (P) against X-31 virus, which recognizes all forms of HA as well as the nucleoprotein (NP), which is a phosphoprotein [32] [33] [34] and can appear as either one or two bands in the gel depending on the phosphorylation status of the protein (A. Ora, Utrecht University, and I.B., unpublished observations). To probe for different conformations, two mouse monoclonal IgG antibodies, F1 and F2, made against nondenatured HA2 were used 6 . The mouse monoclonal antibodies HC3, HC19 and HC100, mapped against epitopes A, B and E, respectively, all in the top domain of HA, have been described 7, 20, 35, 36 . For coimmunoprecipitation with known chaperones, cells were either lysed in 2% (w/v) CHAPS in HBS (50 mM HEPES, pH 7.6, 200 mM NaCl) or in 0.5% (v/v) Triton X-100 lysis buffer (as described above). Cell lysates were precleared with heat-killed and fixed Staphylococcus aureus cells. Immunoprecipitates were washed in 0.5% (w/v) CHAPS in HBS or 0.5% (v/v) Triton X-100 lysis buffer. Coimmunoprecipitation of HA with CNX and CRT from a pulse-chase in intact cells was similar when carried out in Triton X-100 or in CHAPS lysis buffer (B. Kleizen, Utrecht University, and I.B., unpublished observation). The CNX antibody was provided by A. Helenius (ETH, Zürich). The polyclonal antibody against CRT was purchased from Affinity BioReagents. The BiP antibody was purchased from Stressgen, and the PDI antibody has been described 37 . Immunoprecipitated HA was resolved on nonreducing and reducing 7.5% (w/v) SDS-PAGE.
